{"limit": 20, "offset": 0, "total": 5, "items": [{"id": "urn:uuid:cbfcd629-41d9-4ad3-8a5c-2e031fd8a4eb", "category": "biolink:Association", "subject": "CHEBI:3766", "original_subject": null, "subject_namespace": "CHEBI", "subject_category": "biolink:MolecularEntity", "subject_closure": ["CHEBI:37577", "CHEBI:72695", "CHEBI:33285", "CHEBI:33671", "CHEBI:50860", "BFO:0000040", "CHEBI:33661", "CHEBI:25367", "CHEBI:33670", "CHEBI:23117", "CHEBI:33302", "CHEBI:50047", "CHEBI:33860", "CHEBI:46920", "CHEBI:33582", "CHEBI:38166", "CHEBI:38101", "CHEBI:37578", "CHEBI:36683", "CHEBI:22720", "CHEBI:25693", "CHEBI:33659", "CHEBI:24471", "CHEBI:46848", "BFO:0000002", "CHEBI:5686", "CHEBI:33655", "BFO:0000004", "BFO:0000001", "CHEBI:3766", "CHEBI:50996", "CHEBI:33635", "CHEBI:24532", "CHEBI:24431", "CHEBI:51143", "CHEBI:36357", "CHEBI:26144", "CHEBI:33675", "CHEBI:46845", "CHEBI:17792", "CHEBI:23367", "CHEBI:35352", "CHEBI:33595", "CHEBI:33832", "CHEBI:33579"], "subject_label": "clozapine", "subject_closure_label": ["heteromonocyclic compound", "chlorine molecular entity", "organochlorine compound", "benzodiazepine", "continuant", "chemical entity", "nitrogen molecular entity", "monocyclic compound", "independent continuant", "entity", "cyclic compound", "organic cyclic compound", "main group molecular entity", "heteropolycyclic compound", "organic molecular entity", "organohalogen compound", "organic heteromonocyclic compound", "organic aromatic compound", "halide", "aromatic amine", "pnictogen molecular entity", "carbon group molecular entity", "organic amino compound", "N-arylpiperazine", "organic molecule", "heteroorganic entity", "p-block molecular entity", "N-alkylpiperazine", "material entity", "organic heteropolycyclic compound", "organonitrogen heterocyclic compound", "molecular entity", "heteroatomic molecular entity", "aromatic compound", "halogen molecular entity", "N-methylpiperazine", "heterocyclic compound", "molecule", "organonitrogen compound", "clozapine", "tertiary amino compound", "polycyclic compound", "organic heterocyclic compound", "polyatomic entity", "piperazines"], "subject_taxon": null, "subject_taxon_label": null, "predicate": "biolink:related_to", "object": "CHEBI:65191", "original_object": null, "object_namespace": "CHEBI", "object_category": "biolink:Drug", "object_closure": ["CHEBI:35470", "CHEBI:35476", "PATO:0000001", "CHEBI:52217", "CHEBI:35473", "CHEBI:23888", "CHEBI:50906", "BFO:0000002", "CHEBI:65191", "CHEBI:35488", "CHEBI:35471", "CHEBI:33232", "BFO:0000001", "BFO:0000020"], "object_label": "second generation antipsychotic", "object_closure_label": ["antipsychotic agent", "central nervous system drug", "specifically dependent continuant", "entity", "pharmaceutical", "tranquilizing drug", "drug", "central nervous system depressant", "continuant", "quality", "role", "second generation antipsychotic", "application", "psychotropic drug"], "object_taxon": null, "object_taxon_label": null, "primary_knowledge_source": "infores:chebi", "aggregator_knowledge_source": ["infores:monarchinitiative", "infores:phenio"], "negated": null, "pathway": null, "evidence_count": 0, "knowledge_level": "knowledge_assertion", "agent_type": "manual_agent", "has_evidence": [], "has_evidence_links": [], "has_count": null, "has_total": null, "has_percentage": null, "has_quotient": null, "grouping_key": "CHEBI:3766||biolink:related_to|CHEBI:65191", "provided_by": "phenio_edges", "provided_by_link": {"id": "phenio", "url": "https://monarch-initiative.github.io/monarch-ingest/Sources/phenio/#"}, "publications": [], "publications_links": [], "frequency_qualifier": null, "onset_qualifier": null, "sex_qualifier": null, "stage_qualifier": null, "qualifiers": [], "qualifiers_label": null, "qualifiers_namespace": null, "qualifiers_category": null, "qualifiers_closure": [], "qualifiers_closure_label": [], "qualifier": [], "qualifier_label": null, "qualifier_namespace": null, "qualifier_category": null, "qualifier_closure": [], "qualifier_closure_label": [], "frequency_qualifier_label": null, "frequency_qualifier_namespace": null, "frequency_qualifier_category": null, "frequency_qualifier_closure": [], "frequency_qualifier_closure_label": [], "onset_qualifier_label": null, "onset_qualifier_namespace": null, "onset_qualifier_category": null, "onset_qualifier_closure": [], "onset_qualifier_closure_label": [], "sex_qualifier_label": null, "sex_qualifier_namespace": null, "sex_qualifier_category": null, "sex_qualifier_closure": [], "sex_qualifier_closure_label": [], "stage_qualifier_label": null, "stage_qualifier_namespace": null, "stage_qualifier_category": null, "stage_qualifier_closure": [], "stage_qualifier_closure_label": []}, {"id": "urn:uuid:9e6d9d0e-f6ba-4736-9639-c21b2c5fea0b", "category": "biolink:Association", "subject": "CHEBI:7735", "original_subject": null, "subject_namespace": "CHEBI", "subject_category": "biolink:MolecularEntity", "subject_closure": ["CHEBI:72695", "CHEBI:33285", "CHEBI:33671", "CHEBI:50860", "BFO:0000040", "CHEBI:33661", "CHEBI:25367", "CHEBI:33670", "CHEBI:33302", "CHEBI:23367", "CHEBI:50047", "CHEBI:33860", "CHEBI:46920", "CHEBI:33582", "CHEBI:38166", "CHEBI:38101", "CHEBI:7735", "CHEBI:22720", "CHEBI:25693", "CHEBI:33659", "CHEBI:46848", "CHEBI:5686", "CHEBI:33655", "CHEBI:50996", "CHEBI:33635", "CHEBI:24532", "CHEBI:24431", "CHEBI:51143", "BFO:0000004", "CHEBI:36357", "CHEBI:26144", "BFO:0000001", "CHEBI:33675", "CHEBI:46845", "BFO:0000002", "CHEBI:35352", "CHEBI:33595", "CHEBI:33832", "CHEBI:33579"], "subject_label": "olanzapine", "subject_closure_label": ["heteromonocyclic compound", "benzodiazepine", "chemical entity", "nitrogen molecular entity", "monocyclic compound", "cyclic compound", "organic cyclic compound", "main group molecular entity", "heteropolycyclic compound", "organic molecular entity", "continuant", "organic heteromonocyclic compound", "organic aromatic compound", "aromatic amine", "entity", "pnictogen molecular entity", "carbon group molecular entity", "molecular entity", "organic amino compound", "olanzapine", "N-arylpiperazine", "organic molecule", "heteroorganic entity", "p-block molecular entity", "N-alkylpiperazine", "material entity", "organic heteropolycyclic compound", "organonitrogen heterocyclic compound", "aromatic compound", "N-methylpiperazine", "heterocyclic compound", "molecule", "organonitrogen compound", "tertiary amino compound", "polycyclic compound", "organic heterocyclic compound", "independent continuant", "polyatomic entity", "piperazines"], "subject_taxon": null, "subject_taxon_label": null, "predicate": "biolink:related_to", "object": "CHEBI:65191", "original_object": null, "object_namespace": "CHEBI", "object_category": "biolink:Drug", "object_closure": ["CHEBI:35470", "CHEBI:35476", "PATO:0000001", "CHEBI:52217", "CHEBI:35473", "CHEBI:23888", "CHEBI:50906", "BFO:0000002", "CHEBI:65191", "CHEBI:35488", "CHEBI:35471", "CHEBI:33232", "BFO:0000001", "BFO:0000020"], "object_label": "second generation antipsychotic", "object_closure_label": ["antipsychotic agent", "central nervous system drug", "specifically dependent continuant", "entity", "pharmaceutical", "tranquilizing drug", "drug", "central nervous system depressant", "continuant", "quality", "role", "second generation antipsychotic", "application", "psychotropic drug"], "object_taxon": null, "object_taxon_label": null, "primary_knowledge_source": "infores:chebi", "aggregator_knowledge_source": ["infores:monarchinitiative", "infores:phenio"], "negated": null, "pathway": null, "evidence_count": 0, "knowledge_level": "knowledge_assertion", "agent_type": "manual_agent", "has_evidence": [], "has_evidence_links": [], "has_count": null, "has_total": null, "has_percentage": null, "has_quotient": null, "grouping_key": "CHEBI:7735||biolink:related_to|CHEBI:65191", "provided_by": "phenio_edges", "provided_by_link": {"id": "phenio", "url": "https://monarch-initiative.github.io/monarch-ingest/Sources/phenio/#"}, "publications": [], "publications_links": [], "frequency_qualifier": null, "onset_qualifier": null, "sex_qualifier": null, "stage_qualifier": null, "qualifiers": [], "qualifiers_label": null, "qualifiers_namespace": null, "qualifiers_category": null, "qualifiers_closure": [], "qualifiers_closure_label": [], "qualifier": [], "qualifier_label": null, "qualifier_namespace": null, "qualifier_category": null, "qualifier_closure": [], "qualifier_closure_label": [], "frequency_qualifier_label": null, "frequency_qualifier_namespace": null, "frequency_qualifier_category": null, "frequency_qualifier_closure": [], "frequency_qualifier_closure_label": [], "onset_qualifier_label": null, "onset_qualifier_namespace": null, "onset_qualifier_category": null, "onset_qualifier_closure": [], "onset_qualifier_closure_label": [], "sex_qualifier_label": null, "sex_qualifier_namespace": null, "sex_qualifier_category": null, "sex_qualifier_closure": [], "sex_qualifier_closure_label": [], "stage_qualifier_label": null, "stage_qualifier_namespace": null, "stage_qualifier_category": null, "stage_qualifier_closure": [], "stage_qualifier_closure_label": []}, {"id": "urn:uuid:7fd33226-f77c-424e-bffb-284448c8506d", "category": "biolink:Association", "subject": "CHEBI:65173", "original_subject": null, "subject_namespace": "CHEBI", "subject_category": "biolink:MolecularEntity", "subject_closure": ["CHEBI:24062", "CHEBI:37577", "CHEBI:72695", "CHEBI:33285", "CHEBI:76224", "CHEBI:51549", "CHEBI:38104", "CHEBI:33671", "CHEBI:46700", "CHEBI:50860", "CHEBI:33661", "CHEBI:33672", "CHEBI:25367", "CHEBI:33670", "CHEBI:36587", "CHEBI:33302", "CHEBI:51867", "CHEBI:36962", "CHEBI:36963", "CHEBI:37143", "CHEBI:50047", "CHEBI:25698", "BFO:0000001", "CHEBI:33304", "CHEBI:64365", "CHEBI:33582", "CHEBI:38166", "CHEBI:38101", "CHEBI:27171", "CHEBI:37578", "CHEBI:35618", "BFO:0000040", "BFO:0000002", "CHEBI:17087", "CHEBI:25693", "CHEBI:33659", "CHEBI:24471", "CHEBI:33636", "CHEBI:26151", "CHEBI:25806", "CHEBI:51545", "CHEBI:36586", "CHEBI:5686", "CHEBI:33655", "CHEBI:65173", "CHEBI:50996", "CHEBI:33635", "CHEBI:24532", "CHEBI:24431", "CHEBI:51143", "CHEBI:63534", "BFO:0000004", "CHEBI:36357", "CHEBI:33675", "CHEBI:17792", "CHEBI:23367", "CHEBI:35352", "CHEBI:33595", "CHEBI:33832", "CHEBI:33579"], "subject_label": "iloperidone", "subject_closure_label": ["heteromonocyclic compound", "organic oxo compound", "chemical entity", "nitrogen molecular entity", "monocyclic compound", "heterobicyclic compound", "cyclic compound", "organic cyclic compound", "main group molecular entity", "benzisoxazole", "oxacycle", "heteropolycyclic compound", "benzoxazole", "organic molecular entity", "organohalogen compound", "ketone", "organic heteromonocyclic compound", "organic aromatic compound", "halide", "aromatic ether", "pnictogen molecular entity", "methyl ketone", "chalcogen molecular entity", "aralkylamino compound", "carbon group molecular entity", "organooxygen compound", "organofluorine compound", "organic amino compound", "ether", "oxygen molecular entity", "1,2-benzoxazoles", "carbonyl compound", "material entity", "continuant", "organic molecule", "heteroorganic entity", "organic heterobicyclic compound", "p-block molecular entity", "organic heteropolycyclic compound", "organonitrogen heterocyclic compound", "molecular entity", "aromatic ketone", "fluorine molecular entity", "heteroatomic molecular entity", "aromatic compound", "halogen molecular entity", "bicyclic compound", "piperidines", "heterocyclic compound", "molecule", "organonitrogen compound", "iloperidone", "tertiary amino compound", "polycyclic compound", "organic heterocyclic compound", "organochalcogen compound", "monoamine", "independent continuant", "polyatomic entity", "entity"], "subject_taxon": null, "subject_taxon_label": null, "predicate": "biolink:related_to", "object": "CHEBI:65191", "original_object": null, "object_namespace": "CHEBI", "object_category": "biolink:Drug", "object_closure": ["CHEBI:35470", "CHEBI:35476", "PATO:0000001", "CHEBI:52217", "CHEBI:35473", "CHEBI:23888", "CHEBI:50906", "BFO:0000002", "CHEBI:65191", "CHEBI:35488", "CHEBI:35471", "CHEBI:33232", "BFO:0000001", "BFO:0000020"], "object_label": "second generation antipsychotic", "object_closure_label": ["antipsychotic agent", "central nervous system drug", "specifically dependent continuant", "entity", "pharmaceutical", "tranquilizing drug", "drug", "central nervous system depressant", "continuant", "quality", "role", "second generation antipsychotic", "application", "psychotropic drug"], "object_taxon": null, "object_taxon_label": null, "primary_knowledge_source": "infores:chebi", "aggregator_knowledge_source": ["infores:monarchinitiative", "infores:phenio"], "negated": null, "pathway": null, "evidence_count": 0, "knowledge_level": "knowledge_assertion", "agent_type": "manual_agent", "has_evidence": [], "has_evidence_links": [], "has_count": null, "has_total": null, "has_percentage": null, "has_quotient": null, "grouping_key": "CHEBI:65173||biolink:related_to|CHEBI:65191", "provided_by": "phenio_edges", "provided_by_link": {"id": "phenio", "url": "https://monarch-initiative.github.io/monarch-ingest/Sources/phenio/#"}, "publications": [], "publications_links": [], "frequency_qualifier": null, "onset_qualifier": null, "sex_qualifier": null, "stage_qualifier": null, "qualifiers": [], "qualifiers_label": null, "qualifiers_namespace": null, "qualifiers_category": null, "qualifiers_closure": [], "qualifiers_closure_label": [], "qualifier": [], "qualifier_label": null, "qualifier_namespace": null, "qualifier_category": null, "qualifier_closure": [], "qualifier_closure_label": [], "frequency_qualifier_label": null, "frequency_qualifier_namespace": null, "frequency_qualifier_category": null, "frequency_qualifier_closure": [], "frequency_qualifier_closure_label": [], "onset_qualifier_label": null, "onset_qualifier_namespace": null, "onset_qualifier_category": null, "onset_qualifier_closure": [], "onset_qualifier_closure_label": [], "sex_qualifier_label": null, "sex_qualifier_namespace": null, "sex_qualifier_category": null, "sex_qualifier_closure": [], "sex_qualifier_closure_label": [], "stage_qualifier_label": null, "stage_qualifier_namespace": null, "stage_qualifier_category": null, "stage_qualifier_closure": [], "stage_qualifier_closure_label": []}, {"id": "urn:uuid:1ac8ab9f-a7d4-4b3b-acc6-4a182128c41e", "category": "biolink:Association", "subject": "CHEBI:8707", "original_subject": null, "subject_namespace": "CHEBI", "subject_category": "biolink:MolecularEntity", "subject_closure": ["CHEBI:26835", "CHEBI:72695", "CHEBI:33285", "CHEBI:38106", "CHEBI:51958", "CHEBI:33671", "CHEBI:50860", "BFO:0000040", "CHEBI:33661", "CHEBI:25367", "CHEBI:33670", "CHEBI:33302", "CHEBI:36962", "CHEBI:50047", "CHEBI:33860", "CHEBI:33304", "CHEBI:33582", "CHEBI:38166", "CHEBI:38101", "CHEBI:39268", "CHEBI:33261", "CHEBI:26979", "BFO:0000002", "CHEBI:25693", "CHEBI:33659", "CHEBI:46848", "CHEBI:36688", "CHEBI:51959", "CHEBI:5686", "CHEBI:33655", "BFO:0000004", "CHEBI:50996", "CHEBI:33635", "CHEBI:24532", "CHEBI:24431", "CHEBI:51143", "CHEBI:36357", "CHEBI:26144", "BFO:0000001", "CHEBI:33675", "CHEBI:46845", "CHEBI:23367", "CHEBI:8707", "CHEBI:35352", "CHEBI:33595", "CHEBI:33832", "CHEBI:33579"], "subject_label": "quetiapine", "subject_closure_label": ["heteromonocyclic compound", "chemical entity", "nitrogen molecular entity", "monocyclic compound", "organic polycyclic compound", "independent continuant", "cyclic compound", "organic cyclic compound", "main group molecular entity", "heteropolycyclic compound", "organic molecular entity", "organic heteromonocyclic compound", "organic aromatic compound", "dibenzothiazepine", "aromatic amine", "entity", "pnictogen molecular entity", "chalcogen molecular entity", "carbon group molecular entity", "organic amino compound", "organosulfur compound", "organic heterotricyclic compound", "N-arylpiperazine", "heterotricyclic compound", "continuant", "organic molecule", "heteroorganic entity", "organosulfur heterocyclic compound", "p-block molecular entity", "N-alkylpiperazine", "material entity", "organic heteropolycyclic compound", "organonitrogen heterocyclic compound", "molecular entity", "sulfur molecular entity", "aromatic compound", "organic tricyclic compound", "heterocyclic compound", "molecule", "quetiapine", "organonitrogen compound", "tertiary amino compound", "polycyclic compound", "organic heterocyclic compound", "organochalcogen compound", "polyatomic entity", "piperazines"], "subject_taxon": null, "subject_taxon_label": null, "predicate": "biolink:related_to", "object": "CHEBI:65191", "original_object": null, "object_namespace": "CHEBI", "object_category": "biolink:Drug", "object_closure": ["CHEBI:35470", "CHEBI:35476", "PATO:0000001", "CHEBI:52217", "CHEBI:35473", "CHEBI:23888", "CHEBI:50906", "BFO:0000002", "CHEBI:65191", "CHEBI:35488", "CHEBI:35471", "CHEBI:33232", "BFO:0000001", "BFO:0000020"], "object_label": "second generation antipsychotic", "object_closure_label": ["antipsychotic agent", "central nervous system drug", "specifically dependent continuant", "entity", "pharmaceutical", "tranquilizing drug", "drug", "central nervous system depressant", "continuant", "quality", "role", "second generation antipsychotic", "application", "psychotropic drug"], "object_taxon": null, "object_taxon_label": null, "primary_knowledge_source": "infores:chebi", "aggregator_knowledge_source": ["infores:monarchinitiative", "infores:phenio"], "negated": null, "pathway": null, "evidence_count": 0, "knowledge_level": "knowledge_assertion", "agent_type": "manual_agent", "has_evidence": [], "has_evidence_links": [], "has_count": null, "has_total": null, "has_percentage": null, "has_quotient": null, "grouping_key": "CHEBI:8707||biolink:related_to|CHEBI:65191", "provided_by": "phenio_edges", "provided_by_link": {"id": "phenio", "url": "https://monarch-initiative.github.io/monarch-ingest/Sources/phenio/#"}, "publications": [], "publications_links": [], "frequency_qualifier": null, "onset_qualifier": null, "sex_qualifier": null, "stage_qualifier": null, "qualifiers": [], "qualifiers_label": null, "qualifiers_namespace": null, "qualifiers_category": null, "qualifiers_closure": [], "qualifiers_closure_label": [], "qualifier": [], "qualifier_label": null, "qualifier_namespace": null, "qualifier_category": null, "qualifier_closure": [], "qualifier_closure_label": [], "frequency_qualifier_label": null, "frequency_qualifier_namespace": null, "frequency_qualifier_category": null, "frequency_qualifier_closure": [], "frequency_qualifier_closure_label": [], "onset_qualifier_label": null, "onset_qualifier_namespace": null, "onset_qualifier_category": null, "onset_qualifier_closure": [], "onset_qualifier_closure_label": [], "sex_qualifier_label": null, "sex_qualifier_namespace": null, "sex_qualifier_category": null, "sex_qualifier_closure": [], "sex_qualifier_closure_label": [], "stage_qualifier_label": null, "stage_qualifier_namespace": null, "stage_qualifier_category": null, "stage_qualifier_closure": [], "stage_qualifier_closure_label": []}, {"id": "urn:uuid:adc38a72-09f3-426c-92a6-a212b7ccc686", "category": "biolink:Association", "subject": "CHEBI:8871", "original_subject": null, "subject_namespace": "CHEBI", "subject_category": "biolink:MolecularEntity", "subject_closure": ["CHEBI:24062", "CHEBI:37577", "CHEBI:72695", "CHEBI:33285", "CHEBI:51549", "CHEBI:38104", "CHEBI:33671", "CHEBI:46700", "CHEBI:50860", "BFO:0000040", "CHEBI:33661", "CHEBI:33672", "CHEBI:25367", "CHEBI:33670", "CHEBI:33302", "CHEBI:36962", "CHEBI:36963", "CHEBI:37143", "BFO:0000001", "CHEBI:33304", "CHEBI:33582", "CHEBI:38932", "CHEBI:8871", "CHEBI:38166", "CHEBI:38101", "CHEBI:27171", "CHEBI:37578", "CHEBI:25693", "CHEBI:24471", "CHEBI:33636", "CHEBI:26151", "CHEBI:25806", "CHEBI:51545", "CHEBI:5686", "BFO:0000004", "CHEBI:33635", "CHEBI:24532", "CHEBI:24431", "CHEBI:51143", "CHEBI:48585", "CHEBI:36357", "CHEBI:33675", "BFO:0000002", "CHEBI:17792", "CHEBI:23367", "CHEBI:35352", "CHEBI:33595", "CHEBI:33832", "CHEBI:33579"], "subject_label": "risperidone", "subject_closure_label": ["heteromonocyclic compound", "chemical entity", "nitrogen molecular entity", "monocyclic compound", "heterobicyclic compound", "independent continuant", "cyclic compound", "organic cyclic compound", "main group molecular entity", "benzisoxazole", "oxacycle", "heteropolycyclic compound", "benzoxazole", "organic molecular entity", "continuant", "organohalogen compound", "organic heteromonocyclic compound", "halide", "pnictogen molecular entity", "chalcogen molecular entity", "carbon group molecular entity", "pyridopyrimidine", "organooxygen compound", "organofluorine compound", "oxygen molecular entity", "1,2-benzoxazoles", "organic molecule", "heteroorganic entity", "organic heterobicyclic compound", "p-block molecular entity", "material entity", "risperidone", "organic heteropolycyclic compound", "organonitrogen heterocyclic compound", "molecular entity", "fluorine molecular entity", "heteroatomic molecular entity", "halogen molecular entity", "bicyclic compound", "piperidines", "heterocyclic compound", "molecule", "organonitrogen compound", "polycyclic compound", "organic heterocyclic compound", "organochalcogen compound", "heteroarylpiperidine", "polyatomic entity", "entity"], "subject_taxon": null, "subject_taxon_label": null, "predicate": "biolink:related_to", "object": "CHEBI:65191", "original_object": null, "object_namespace": "CHEBI", "object_category": "biolink:Drug", "object_closure": ["CHEBI:35470", "CHEBI:35476", "PATO:0000001", "CHEBI:52217", "CHEBI:35473", "CHEBI:23888", "CHEBI:50906", "BFO:0000002", "CHEBI:65191", "CHEBI:35488", "CHEBI:35471", "CHEBI:33232", "BFO:0000001", "BFO:0000020"], "object_label": "second generation antipsychotic", "object_closure_label": ["antipsychotic agent", "central nervous system drug", "specifically dependent continuant", "entity", "pharmaceutical", "tranquilizing drug", "drug", "central nervous system depressant", "continuant", "quality", "role", "second generation antipsychotic", "application", "psychotropic drug"], "object_taxon": null, "object_taxon_label": null, "primary_knowledge_source": "infores:chebi", "aggregator_knowledge_source": ["infores:monarchinitiative", "infores:phenio"], "negated": null, "pathway": null, "evidence_count": 0, "knowledge_level": "knowledge_assertion", "agent_type": "manual_agent", "has_evidence": [], "has_evidence_links": [], "has_count": null, "has_total": null, "has_percentage": null, "has_quotient": null, "grouping_key": "CHEBI:8871||biolink:related_to|CHEBI:65191", "provided_by": "phenio_edges", "provided_by_link": {"id": "phenio", "url": "https://monarch-initiative.github.io/monarch-ingest/Sources/phenio/#"}, "publications": [], "publications_links": [], "frequency_qualifier": null, "onset_qualifier": null, "sex_qualifier": null, "stage_qualifier": null, "qualifiers": [], "qualifiers_label": null, "qualifiers_namespace": null, "qualifiers_category": null, "qualifiers_closure": [], "qualifiers_closure_label": [], "qualifier": [], "qualifier_label": null, "qualifier_namespace": null, "qualifier_category": null, "qualifier_closure": [], "qualifier_closure_label": [], "frequency_qualifier_label": null, "frequency_qualifier_namespace": null, "frequency_qualifier_category": null, "frequency_qualifier_closure": [], "frequency_qualifier_closure_label": [], "onset_qualifier_label": null, "onset_qualifier_namespace": null, "onset_qualifier_category": null, "onset_qualifier_closure": [], "onset_qualifier_closure_label": [], "sex_qualifier_label": null, "sex_qualifier_namespace": null, "sex_qualifier_category": null, "sex_qualifier_closure": [], "sex_qualifier_closure_label": [], "stage_qualifier_label": null, "stage_qualifier_namespace": null, "stage_qualifier_category": null, "stage_qualifier_closure": [], "stage_qualifier_closure_label": []}]}